Literature DB >> 12036043

Characteristics of lysophosphatidylcholine in its inhibition of taurine uptake by human intestinal Caco-2 cells.

Koji Ishizuka1, Yusei Miyamoto, Hideo Satsu, Ryuichiro Sato, Makoto Shimizu.   

Abstract

The characteristics of lysophosphatidylcholine (LPC) in its inhibition of the taurine uptake by human intestinal Caco-2 cells were investigated. By treating the cells with 200 microM of LPC, the taurine uptake was rapidly decreased by approximately 60%. This decrease was accompanied by an increase in the Km value for the uptake. A rapid uptake of LPC itself by the cells was also observed. The inhibitory activity of LPC was specific to the uptake of taurine and certain amino acids, while the uptake of glucose, glutamic acid and peptide (glycylglutamine) was not affected by LPC. The activity was dependent on the structure of a polar head and the bound fatty acid. The phosphorylcholine residue was likely to have played an important role, and surface active LPC with fatty acids of C14 or longer was highly inhibitory. These results suggest that the interaction of LPC with the taurine transporter in the intestinal cell membrane was the cause of the reduced taurine uptake.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12036043     DOI: 10.1271/bbb.66.730

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  3 in total

1.  Functional characterization and regulation of the taurine transporter and cysteine dioxygenase in human hepatoblastoma HepG2 cells.

Authors:  Hideo Satsu; Eriko Terasawa; Yu Hosokawa; Makoto Shimizu
Journal:  Biochem J       Date:  2003-10-15       Impact factor: 3.857

Review 2.  Taurine biosynthetic enzymes and taurine transporter: molecular identification and regulations.

Authors:  M L Tappaz
Journal:  Neurochem Res       Date:  2004-01       Impact factor: 3.996

Review 3.  Significance of taurine transporter (TauT) in homeostasis and its layers of regulation (Review).

Authors:  Stella Baliou; Anthony M Kyriakopoulos; Maria Goulielmaki; Michalis I Panayiotidis; Demetrios A Spandidos; Vassilios Zoumpourlis
Journal:  Mol Med Rep       Date:  2020-07-09       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.